Loading clinical trials...
Loading clinical trials...
The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
Age
35 - 85 years
Sex
ALL
Healthy Volunteers
Yes
Cardiovascular Aging Research Lab at UT Austin
Austin, Texas, United States
Start Date
April 1, 2023
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2024
Last Updated
May 10, 2023
15
ESTIMATED participants
Rhamnan sulfate
DIETARY_SUPPLEMENT
Lead Sponsor
University of Texas at Austin
Collaborators
NCT06909773
NCT06505109
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06189313